About one in four healthcare workers in the United Kingdom who caught COVID-19 went on to report symptoms lasting five weeks or longer, according to a research program examining the pandemic's lasting effect on the health workforce.
The REACH-OUT report was produced by the NHS Race and Health Observatory in partnership with UK-REACH and in collaboration with the University of Leicester, the University of Nottingham and University College London. It launched at a Westminster event on July 30 and has drawn renewed attention through subsequent coverage.
It is a British study of a British workforce, and its headline figures should not be read as United States prevalence estimates. What it offers American readers is something harder to get domestically: a sustained look at what happens to the people who staff hospitals after they get infected at work.
The Numbers Behind the Headline Figure
The program combined a global systematic review with surveys of UK healthcare workers and interviews with workers, managers and support networks. The mixed methods work collected data from 2022 to 2025 and drew on survey responses from more than 11,500 UK healthcare workers, as summarized by CIDRAP at the University of Minnesota.
The review side pooled results from studies covering 6,418 healthcare workers worldwide. An estimated 40 percent of those who contracted COVID still had symptoms at an average follow up of 22 weeks. Among workers followed for a full year, 26.5 percent continued to report symptoms.
The one in four framing comes from the UK survey data, where about a quarter of previously infected workers reported symptoms persisting five weeks or longer, and a separate reading put the figure at 27 percent. Those are different thresholds measured at different points, which is a reason to treat any single headline percentage with care. The report itself defines long COVID as symptoms lasting at least three months after infection.
Fatigue was the most commonly reported symptom. Neurological complaints such as brain fog and headache followed, along with loss of taste or smell, muscle pain and shortness of breath. The University of Leicester, which led the work, has published the full report through its NIHR research center.
The Distribution Nobody Should Skip Over
The finding that gives the report its institutional home is about who carried the burden, and the draft version of this story buried it.
"People from Black, Asian and ethnic minority backgrounds shouldered a disproportionate burden in the COVID-19 pandemic," said Professor Habib Naqvi, chief executive of the NHS Race and Health Observatory. "There is a clear and urgent need for improved workplace adjustments, tailored support for the workforce, and increased learning and understanding of the impact of long COVID for the wider health and care system. We simply cannot afford for history to repeat itself."
Among the program's stated objectives was examining the demographic, clinical, occupational and sociocultural factors associated with long COVID risk, with particular attention to ethnicity, migration status and vaccination history. Risk was not evenly distributed by other measures either, with women, people with preexisting conditions and those whose initial infections were severe more likely to report prolonged symptoms.
"Doing this work, it became clear how little evidence existed for this population on a condition we still understand relatively poorly," said Dr Amani Al-Oraibi of the University of Nottingham, the REACH-OUT lead. "My hope now is that researchers and policymakers use these findings as a genuine starting point and that we see real change for a workforce that gave so much to support all of us, and deserves to be supported in return."
Presenteeism, Stigma and the Staffing Consequence
The interview portion describes a dynamic familiar to anyone who has worked in a hospital. Workers reported pressure to keep going while unwell and worried about how illness would be perceived by colleagues. Continuing to work while sick delayed them from seeking help and may have contributed to symptoms worsening. Unpredictable relapses, fatigue and cognitive difficulty made the work itself harder to perform. The findings point to prolonged absences, reduced productivity and staff working while unwell, with affected workers describing the support they received as inconsistent and insufficient.
This is where a British workforce study reaches American households. Hospital staffing shortages are not abstract. They show up as longer emergency department waits, delayed procedures and reduced availability of specialists. A workforce carrying a substantial burden of prolonged post-viral symptoms is a workforce with less capacity, and patients absorb that difference.
The report urges workplace accommodations including flexible return to work pathways, reduced hours and hybrid working where possible, along with accessible physical, psychological and occupational therapy, and funding for further research into persistent post-viral symptoms. Professor Manish Pareek of the University of Leicester, chief investigator of UK-REACH and REACH-OUT, framed the case plainly, calling healthcare workers the NHS's greatest asset and their wellbeing critical to delivering safe care.
Limits of the Evidence and Where It Goes Next
Several caveats matter. Much of the data rests on worker self-report rather than clinical assessment, and the definition of long COVID varied between the studies pooled in the review. Surveys conducted earlier in the pandemic captured a different virus, a different vaccination landscape, and a different treatment environment than exists now, so current incidence after a 2026 infection is likely lower than these figures suggest.
The systematic review covered 6,418 workers across studies of varying design and quality, which is a reasonable evidence base for describing a pattern but not for producing a precise national estimate. Researchers have said supporting those affected and preventing similar impacts in future pandemics should remain a priority.
No clinical guidance has changed as a result of this report. It is a research synthesis with policy recommendations directed primarily at NHS employers. Whether those recommendations are adopted, and whether comparable data are ever collected for the American health workforce, are both open questions.
Key Questions Answered
Is this a United States study? No. It examined the United Kingdom health workforce and was produced by the NHS Race and Health Observatory with UK-REACH and three British universities. Its systematic review component included studies of healthcare workers worldwide.
What does one in four actually refer to? UK survey findings that about a quarter of previously infected healthcare workers reported symptoms lasting five weeks or longer, with a separate reading at 27 percent. Those are different thresholds, and the report defines long COVID as symptoms lasting at least three months.
What were the most common symptoms? Fatigue was most commonly reported, followed by neurological symptoms such as brain fog and headache, loss of taste or smell, muscle pain, and shortness of breath.
Who faced the highest burden? The report emphasizes that people from Black, Asian, and ethnic minority backgrounds shouldered a disproportionate burden during the pandemic. Women, people with preexisting conditions, and those with severe initial infections were also more likely to report prolonged symptoms.
Why does a British workforce study matter to American patients? Because staffing capacity determines waiting times, procedure scheduling, and specialist availability. A workforce carrying prolonged post-viral illness has less capacity, and patients experience that as delay.
Does this change any medical guidance? No. The report is a research synthesis with workplace policy recommendations aimed primarily at NHS employers. No clinical guidance has changed as a result.
